Updates

Equals Group - New name for FairFX

July 2019

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Equals Group is the new name for FairFX as of 26 June.Earlier in the month, Equals said it has been granted permission by the FCA to provide credit facilities acting as a broker for third party lenders. Clearing this key regulatory hurdle allows it to offer loans to its customers and Equals will launch a loan product in partnership with iwoca, one of Europe's largest business lenders, in due course. Keep holding. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Eckoh

Scientific Digital Imaging

Equals Group (February 2024)

Equals (October 2023)

Equals (August 2023)

Equals - Scope for material outperformance (June 2023)

Equals - Forecasts upgraded by 16% (April 2023)

Equals (May 2021)

Equals Group - Sales pivot to B2B - now 66% sales (November 2020)

Equals Group (March 2020)

Equals Group (November 2019)

Equals Group - Placing and open offer to raise Â£16m (September 2019)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X